ArticleAcute medicine & surgery
Significance of Serum Neuron-Specific Enolase in Patients With Sepsis and Its Association With Inflammatory Biomarkers.
Article in Acute medicine & surgery. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Although survival rates in sepsis cases have improved, functional outcomes remain poor in many cases. The aim of this study was to investigate the significance and interrelationship of serum neurological and inflammatory biomarkers in patients with sepsis. Methods: Patients with sepsis who had good activities of daily living before admission were included. The following biomarkers were examined at 0, 1, and 3 days after admission: neuron-specific enolase (NSE); S100β; high mobility group box 1 (HMGB1); interleukins 1, 6, and 8 (IL-1, IL-6, and IL-8); interferon-gamma (IFN-γ); and tumor necrosis factor-alpha (TNF-α). Functional outcomes were defined using the modified Rankin Scale, with scores of 1 and 2 categorized as favorable outcomes. Results: Among the 53 patients, 5 (9%) were non-survivors, and 8 (15%) were survivors with favorable outcomes. Biomarker analysis revealed significantly elevated levels of NSE, HMGB1, IL-1, IL-6, IL-8, and IFN-γ in non-survivors; however, no difference was observed in functional prognosis. On day 3, a significant association was observed between NSE and HMGB1, IL-1, IL-6, IL-8, and IFN-γ. Conclusions: Elevated NSE levels were observed in non-surviving patients with sepsis, and NSE levels on day 3 were significantly correlated with the other inflammation-related biomarkers. These findings suggest that the progression of brain damage due to sepsis may be associated with inflammation, highlighting a potential target for future therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.